Get the Stockscreener App
17.60
1.62%
0.28
After Hours:
17.60
Caredx Inc stock is traded at $17.60, with a volume of 380.09K.
It is up +1.62% in the last 24 hours and down -9.47% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.32
Open:
$17.44
24h Volume:
380.09K
Relative Volume:
0.55
Market Cap:
$901.41M
Revenue:
$358.00M
Net Income/Loss:
$70.45M
P/E Ratio:
14.76
EPS:
1.1924
Net Cash Flow:
$36.42M
1W Performance:
+3.65%
1M Performance:
-9.47%
6M Performance:
+23.08%
1Y Performance:
-8.67%
1-Day Range:
$17.41
$17.80
1-Week Range:
$16.27
$17.80
52-Week Range:
$10.96
$21.48
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
17.60 | 887.07M | 358.00M | 70.45M | 36.42M | 1.1924 |
|
TMO
Thermo Fisher Scientific Inc
|
472.71 | 174.60B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.21 | 135.34B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
586.98 | 46.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.75 | 31.60B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
296.99 | 28.45B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA - MarketBeat
CDNA,SPOK Options - Finviz
How The CareDx (CDNA) Story Is Shifting With CMS LCD Uncertainty And New Guidance - Yahoo Finance
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
CareDx introduces VANTx AI platform for complex transplant datasets - MSN
Braidwell LP Makes New Investment in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC - MarketBeat
Prosight Management LP Grows Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA - MarketBeat
(CDNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Launches VANTx AI Solution for Advanced Transplant Data Analysis - Bitget
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets - Zacks Investment Research
CareDx reports positive data for AlloHeme in AML and MDS post HCT - MSN
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference - MarketBeat
Paragon Associates & Paragon Associates II Joint Venture Buys 205,597 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
CareDx launches AI platform for transplant research - Investing.com Australia
CareDx launches AI platform for transplant research By Investing.com - Investing.com Canada
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks - TipRanks
CareDx (CDNA) Introduces VANTx: A Revolutionary AI Data Platform for Transplants - GuruFocus
FinancialContentCareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - FinancialContent
Royce & Associates LP Has $5.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
First Eagle Investment Management LLC Buys 96,123 Shares of CareDx, Inc. $CDNA - MarketBeat
ARK Investment Management LLC Buys 70,468 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Amova Asset Management Americas Inc. - MarketBeat
Caredex Stock Quote, Share Price, News and Analysis - Longbridge
(CDNA) Risk Channels and Responsive Allocation - Stock Traders Daily
CareDx Issues Inducement Grants With Stock Options and RSUs for New Employees - geneonline.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI) - The Globe and Mail
BTIG Raises CareDx (CDNA) Price Target to $26.00, Maintains Buy Rating | CDNA Stock News - GuruFocus
BTIG raises CareDx stock price target to $26 on strong Q4 results - Investing.com India
CareDx (CDNA) Returns To Q4 Loss As Revenue Growth Tests Bullish Narratives - simplywall.st
CareDx, Inc Q4 2025 Earnings Call Summary - Yahoo Finance
BTIG raises CareDx stock price target to $26 on strong Q4 results By Investing.com - Investing.com South Africa
CareDx (CDNA) grows 2025 revenue 14% and guides higher for 2026 - Stock Titan
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating - TipRanks
CareDx Names COO to Additional CFO Post - Contract Pharma
CareDx (CDNA) Receives Rating Update: Wells Fargo Raises Price T - GuruFocus
CareDx (NASDAQ:CDNA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
CareDx (NASDAQ:CDNA) Shares Gap Down After Earnings Miss - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q4 2025 Earnings Call Transcript - Insider Monkey
CareDx: Fourth Quarter Financial Overview - Bitget
CareDx Inc (CDNA) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
CareDx Q4 Earnings Call Highlights - MarketBeat
CareDx, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CDNA) 2026-02-24 - Seeking Alpha
CareDx names COO Keith Kennedy as chief financial officer - Investing.com India
CareDx (CDNA) Q4 2025 Earnings Call Transcript - AOL.com
CareDx names COO Keith Kennedy as chief financial officer By Investing.com - Investing.com Australia
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):